H-1B sponsorship profile: Scribe Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Scribe Therapeutics Inc filed 10 Labor Condition Applications covering 10 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (10 certified of 10 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Scribe Therapeutics Inc’s H-1B petitions range from $82,576 at the low end to $195,000 at the high end, with a petition-weighted average of $136,790. That range reflects the mix of occupations the company sponsors, led by Scientist I (2 petitions at $125,977 avg), followed by Senior Scientist II and Senior Research Associate I. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Scribe Therapeutics Inc is headquartered in Alameda, CA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Scribe Therapeutics Inc ranks. By H-1B petition volume, Scribe Therapeutics Inc is #16,610 of 119,880 employers nationally and #2,625 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.